Skip to content

Study on the Value of Three DWI Scanning Sequences in Staging of Gastric Cancer

Comparative Study on the Value of Three DWI Scan Sequences of 3.0T Magnetic Resonance in Staging of Gastric Cancer

Status
Recruiting
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT06735105
Enrollment
129
Registered
2024-12-16
Start date
2023-12-23
Completion date
2024-12-31
Last updated
2024-12-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Gastric Cancer

Brief summary

Accurate staging is critical for effective gastric cancer treatment planning. Conventional DWI (C-DWI) has limitations in image quality due to magnetic field inhomogeneity, which hampers precise T staging. This study aims to compare the image quality and T staging accuracy of C-DWI, TSE-DWI, and ZOOMit-DWI (Z-DWI) sequences in MRI examinations of gastric cancer patients. A prospective study plan to enroll 72 gastric cancer patients undergoing preoperative MRI with C-DWI, TSE-DWI, and Z-DWI sequences using a 3.0 T scanner. Quantitative metrics (ADC, SNR, CNR) and image quality were evaluated. T staging accuracy was assessed by comparing MRI results with postoperative pathological staging using ROC analysis.

Interventions

DIAGNOSTIC_TESTScanning parameter

Based on abdominal scanning, TSE-DWI,ZOOMIT DWI and EPI-DWI scans were performed, and the study was divided into two steps according to the nanomotion criteria. The first step was self-controlled, which was divided into experimental group and control group. The experimental group included TSE-DWI,ZOOMit DWI, and the control group included EPI-DWI. Then the image quality was evaluated by subjective and objective evaluation indexes. In the second step, the three DWI stages were performed separately by four diagnosticians, with an interval of 1 month, and statistical analysis was performed at the end.

Sponsors

Yunnan Cancer Hospital
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
DIAGNOSTIC
Masking
DOUBLE (Subject, Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
18 Years to 80 Years
Healthy volunteers
Yes

Inclusion criteria

1. The patient was diagnosed with gastric cancer by pathological biopsy 2. No biopsy was taken within 1 week before MR Examination to rule out the effect of bleeding on the image 3. No contraindications for MRI examination; And exclude serious heart, liver, kidney, cerebrovascular diseases.

Exclusion criteria

1. The image quality cannot meet the diagnostic criteria; 2. Patients could not tolerate MRI examination, resulting in incomplete MR-related sequence image data.

Design outcomes

Primary

MeasureTime frameDescription
T staging of gastric cancerone yearStudy on the value of three DWI scanning sequences in T staging of gastric cancer

Countries

China

Contacts

Primary ContactLi Yanli, master
lyl2241@163.com18987958050
Backup ContactLi Zhenhui, MD
lizhenhui@kmmu.edu.cn13698736132

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026